Gene Therapy-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data
Report Summary
Gene Therapy-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on Gene Therapy industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Gene Therapy 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Gene Therapy worldwide and market share by regions, with company and product introduction, position in the Gene Therapy market
Market status and development trend of Gene Therapy by types and applications
Cost and profit status of Gene Therapy, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Gene Therapy market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Gene Therapy industry.
The report segments the global Gene Therapy market as:
Global Gene Therapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Gene Therapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Viral Gene Therapy
Non-Viral Gene Therapy
Global Gene Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
Neurological Diseases
Cancer
Other
Global Gene Therapy Market: Manufacturers Segment Analysis (Company and Product introduction, Gene Therapy Sales Volume, Revenue, Price and Gross Margin):
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Gene Therapy-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on Gene Therapy industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Gene Therapy 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Gene Therapy worldwide and market share by regions, with company and product introduction, position in the Gene Therapy market
Market status and development trend of Gene Therapy by types and applications
Cost and profit status of Gene Therapy, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Gene Therapy market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Gene Therapy industry.
The report segments the global Gene Therapy market as:
Global Gene Therapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Gene Therapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Viral Gene Therapy
Non-Viral Gene Therapy
Global Gene Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
Neurological Diseases
Cancer
Other
Global Gene Therapy Market: Manufacturers Segment Analysis (Company and Product introduction, Gene Therapy Sales Volume, Revenue, Price and Gross Margin):
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF GENE THERAPY
1.1 Definition of Gene Therapy in This Report
1.2 Commercial Types of Gene Therapy
1.2.1 Viral Gene Therapy
1.2.2 Non-Viral Gene Therapy
1.3 Downstream Application of Gene Therapy
1.3.1 Neurological Diseases
1.3.2 Cancer
1.3.3 Other
1.4 Development History of Gene Therapy
1.5 Market Status and Trend of Gene Therapy 2016-2026
1.5.1 Global Gene Therapy Market Status and Trend 2016-2026
1.5.2 Regional Gene Therapy Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Gene Therapy 2016-2021
2.2 Sales Market of Gene Therapy by Regions
2.2.1 Sales Volume of Gene Therapy by Regions
2.2.2 Sales Value of Gene Therapy by Regions
2.3 Production Market of Gene Therapy by Regions
2.4 Global Market Forecast of Gene Therapy 2022-2026
2.4.1 Global Market Forecast of Gene Therapy 2022-2026
2.4.2 Market Forecast of Gene Therapy by Regions 2022-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Gene Therapy by Types
3.2 Sales Value of Gene Therapy by Types
3.3 Market Forecast of Gene Therapy by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Gene Therapy by Downstream Industry
4.2 Global Market Forecast of Gene Therapy by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Gene Therapy Market Status by Countries
5.1.1 North America Gene Therapy Sales by Countries (2016-2021)
5.1.2 North America Gene Therapy Revenue by Countries (2016-2021)
5.1.3 United States Gene Therapy Market Status (2016-2021)
5.1.4 Canada Gene Therapy Market Status (2016-2021)
5.1.5 Mexico Gene Therapy Market Status (2016-2021)
5.2 North America Gene Therapy Market Status by Manufacturers
5.3 North America Gene Therapy Market Status by Type (2016-2021)
5.3.1 North America Gene Therapy Sales by Type (2016-2021)
5.3.2 North America Gene Therapy Revenue by Type (2016-2021)
5.4 North America Gene Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Gene Therapy Market Status by Countries
6.1.1 Europe Gene Therapy Sales by Countries (2016-2021)
6.1.2 Europe Gene Therapy Revenue by Countries (2016-2021)
6.1.3 Germany Gene Therapy Market Status (2016-2021)
6.1.4 UK Gene Therapy Market Status (2016-2021)
6.1.5 France Gene Therapy Market Status (2016-2021)
6.1.6 Italy Gene Therapy Market Status (2016-2021)
6.1.7 Russia Gene Therapy Market Status (2016-2021)
6.1.8 Spain Gene Therapy Market Status (2016-2021)
6.1.9 Benelux Gene Therapy Market Status (2016-2021)
6.2 Europe Gene Therapy Market Status by Manufacturers
6.3 Europe Gene Therapy Market Status by Type (2016-2021)
6.3.1 Europe Gene Therapy Sales by Type (2016-2021)
6.3.2 Europe Gene Therapy Revenue by Type (2016-2021)
6.4 Europe Gene Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Gene Therapy Market Status by Countries
7.1.1 Asia Pacific Gene Therapy Sales by Countries (2016-2021)
7.1.2 Asia Pacific Gene Therapy Revenue by Countries (2016-2021)
7.1.3 China Gene Therapy Market Status (2016-2021)
7.1.4 Japan Gene Therapy Market Status (2016-2021)
7.1.5 India Gene Therapy Market Status (2016-2021)
7.1.6 Southeast Asia Gene Therapy Market Status (2016-2021)
7.1.7 Australia Gene Therapy Market Status (2016-2021)
7.2 Asia Pacific Gene Therapy Market Status by Manufacturers
7.3 Asia Pacific Gene Therapy Market Status by Type (2016-2021)
7.3.1 Asia Pacific Gene Therapy Sales by Type (2016-2021)
7.3.2 Asia Pacific Gene Therapy Revenue by Type (2016-2021)
7.4 Asia Pacific Gene Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Gene Therapy Market Status by Countries
8.1.1 Latin America Gene Therapy Sales by Countries (2016-2021)
8.1.2 Latin America Gene Therapy Revenue by Countries (2016-2021)
8.1.3 Brazil Gene Therapy Market Status (2016-2021)
8.1.4 Argentina Gene Therapy Market Status (2016-2021)
8.1.5 Colombia Gene Therapy Market Status (2016-2021)
8.2 Latin America Gene Therapy Market Status by Manufacturers
8.3 Latin America Gene Therapy Market Status by Type (2016-2021)
8.3.1 Latin America Gene Therapy Sales by Type (2016-2021)
8.3.2 Latin America Gene Therapy Revenue by Type (2016-2021)
8.4 Latin America Gene Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Gene Therapy Market Status by Countries
9.1.1 Middle East and Africa Gene Therapy Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Gene Therapy Revenue by Countries (2016-2021)
9.1.3 Middle East Gene Therapy Market Status (2016-2021)
9.1.4 Africa Gene Therapy Market Status (2016-2021)
9.2 Middle East and Africa Gene Therapy Market Status by Manufacturers
9.3 Middle East and Africa Gene Therapy Market Status by Type (2016-2021)
9.3.1 Middle East and Africa Gene Therapy Sales by Type (2016-2021)
9.3.2 Middle East and Africa Gene Therapy Revenue by Type (2016-2021)
9.4 Middle East and Africa Gene Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF GENE THERAPY
10.1 Global Economy Situation and Trend Overview
10.2 Gene Therapy Downstream Industry Situation and Trend Overview
CHAPTER 11 GENE THERAPY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Gene Therapy by Major Manufacturers
11.2 Production Value of Gene Therapy by Major Manufacturers
11.3 Basic Information of Gene Therapy by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Gene Therapy Major Manufacturer
11.3.2 Employees and Revenue Level of Gene Therapy Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 GENE THERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Biogen
12.1.1 Company profile
12.1.2 Representative Gene Therapy Product
12.1.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Biogen
12.2 Novartis
12.2.1 Company profile
12.2.2 Representative Gene Therapy Product
12.2.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Novartis
12.3 Gilead Sciences
12.3.1 Company profile
12.3.2 Representative Gene Therapy Product
12.3.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Gilead Sciences
12.4 Sarepta Therapeutics
12.4.1 Company profile
12.4.2 Representative Gene Therapy Product
12.4.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Sarepta Therapeutics
12.5 Alnylam Pharmaceuticals
12.5.1 Company profile
12.5.2 Representative Gene Therapy Product
12.5.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Alnylam Pharmaceuticals
12.6 Amgen
12.6.1 Company profile
12.6.2 Representative Gene Therapy Product
12.6.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Amgen
12.7 Spark Therapeutics
12.7.1 Company profile
12.7.2 Representative Gene Therapy Product
12.7.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Spark Therapeutics
12.8 Akcea Therapeutics
12.8.1 Company profile
12.8.2 Representative Gene Therapy Product
12.8.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Akcea Therapeutics
12.9 bluebird bio
12.9.1 Company profile
12.9.2 Representative Gene Therapy Product
12.9.3 Gene Therapy Sales, Revenue, Price and Gross Margin of bluebird bio
12.10 Sunway Biotech
12.10.1 Company profile
12.10.2 Representative Gene Therapy Product
12.10.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Sunway Biotech
12.11 SIBIONO
12.11.1 Company profile
12.11.2 Representative Gene Therapy Product
12.11.3 Gene Therapy Sales, Revenue, Price and Gross Margin of SIBIONO
12.12 AnGes
12.12.1 Company profile
12.12.2 Representative Gene Therapy Product
12.12.3 Gene Therapy Sales, Revenue, Price and Gross Margin of AnGes
12.13 Orchard Therapeutics
12.13.1 Company profile
12.13.2 Representative Gene Therapy Product
12.13.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Orchard Therapeutics
12.14 Human Stem Cells Institute
12.14.1 Company profile
12.14.2 Representative Gene Therapy Product
12.14.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Human Stem Cells Institute
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GENE THERAPY
13.1 Industry Chain of Gene Therapy
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF GENE THERAPY
14.1 Cost Structure Analysis of Gene Therapy
14.2 Raw Materials Cost Analysis of Gene Therapy
14.3 Labor Cost Analysis of Gene Therapy
14.4 Manufacturing Expenses Analysis of Gene Therapy
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Gene Therapy in This Report
1.2 Commercial Types of Gene Therapy
1.2.1 Viral Gene Therapy
1.2.2 Non-Viral Gene Therapy
1.3 Downstream Application of Gene Therapy
1.3.1 Neurological Diseases
1.3.2 Cancer
1.3.3 Other
1.4 Development History of Gene Therapy
1.5 Market Status and Trend of Gene Therapy 2016-2026
1.5.1 Global Gene Therapy Market Status and Trend 2016-2026
1.5.2 Regional Gene Therapy Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Gene Therapy 2016-2021
2.2 Sales Market of Gene Therapy by Regions
2.2.1 Sales Volume of Gene Therapy by Regions
2.2.2 Sales Value of Gene Therapy by Regions
2.3 Production Market of Gene Therapy by Regions
2.4 Global Market Forecast of Gene Therapy 2022-2026
2.4.1 Global Market Forecast of Gene Therapy 2022-2026
2.4.2 Market Forecast of Gene Therapy by Regions 2022-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Gene Therapy by Types
3.2 Sales Value of Gene Therapy by Types
3.3 Market Forecast of Gene Therapy by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Gene Therapy by Downstream Industry
4.2 Global Market Forecast of Gene Therapy by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Gene Therapy Market Status by Countries
5.1.1 North America Gene Therapy Sales by Countries (2016-2021)
5.1.2 North America Gene Therapy Revenue by Countries (2016-2021)
5.1.3 United States Gene Therapy Market Status (2016-2021)
5.1.4 Canada Gene Therapy Market Status (2016-2021)
5.1.5 Mexico Gene Therapy Market Status (2016-2021)
5.2 North America Gene Therapy Market Status by Manufacturers
5.3 North America Gene Therapy Market Status by Type (2016-2021)
5.3.1 North America Gene Therapy Sales by Type (2016-2021)
5.3.2 North America Gene Therapy Revenue by Type (2016-2021)
5.4 North America Gene Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Gene Therapy Market Status by Countries
6.1.1 Europe Gene Therapy Sales by Countries (2016-2021)
6.1.2 Europe Gene Therapy Revenue by Countries (2016-2021)
6.1.3 Germany Gene Therapy Market Status (2016-2021)
6.1.4 UK Gene Therapy Market Status (2016-2021)
6.1.5 France Gene Therapy Market Status (2016-2021)
6.1.6 Italy Gene Therapy Market Status (2016-2021)
6.1.7 Russia Gene Therapy Market Status (2016-2021)
6.1.8 Spain Gene Therapy Market Status (2016-2021)
6.1.9 Benelux Gene Therapy Market Status (2016-2021)
6.2 Europe Gene Therapy Market Status by Manufacturers
6.3 Europe Gene Therapy Market Status by Type (2016-2021)
6.3.1 Europe Gene Therapy Sales by Type (2016-2021)
6.3.2 Europe Gene Therapy Revenue by Type (2016-2021)
6.4 Europe Gene Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Gene Therapy Market Status by Countries
7.1.1 Asia Pacific Gene Therapy Sales by Countries (2016-2021)
7.1.2 Asia Pacific Gene Therapy Revenue by Countries (2016-2021)
7.1.3 China Gene Therapy Market Status (2016-2021)
7.1.4 Japan Gene Therapy Market Status (2016-2021)
7.1.5 India Gene Therapy Market Status (2016-2021)
7.1.6 Southeast Asia Gene Therapy Market Status (2016-2021)
7.1.7 Australia Gene Therapy Market Status (2016-2021)
7.2 Asia Pacific Gene Therapy Market Status by Manufacturers
7.3 Asia Pacific Gene Therapy Market Status by Type (2016-2021)
7.3.1 Asia Pacific Gene Therapy Sales by Type (2016-2021)
7.3.2 Asia Pacific Gene Therapy Revenue by Type (2016-2021)
7.4 Asia Pacific Gene Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Gene Therapy Market Status by Countries
8.1.1 Latin America Gene Therapy Sales by Countries (2016-2021)
8.1.2 Latin America Gene Therapy Revenue by Countries (2016-2021)
8.1.3 Brazil Gene Therapy Market Status (2016-2021)
8.1.4 Argentina Gene Therapy Market Status (2016-2021)
8.1.5 Colombia Gene Therapy Market Status (2016-2021)
8.2 Latin America Gene Therapy Market Status by Manufacturers
8.3 Latin America Gene Therapy Market Status by Type (2016-2021)
8.3.1 Latin America Gene Therapy Sales by Type (2016-2021)
8.3.2 Latin America Gene Therapy Revenue by Type (2016-2021)
8.4 Latin America Gene Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Gene Therapy Market Status by Countries
9.1.1 Middle East and Africa Gene Therapy Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Gene Therapy Revenue by Countries (2016-2021)
9.1.3 Middle East Gene Therapy Market Status (2016-2021)
9.1.4 Africa Gene Therapy Market Status (2016-2021)
9.2 Middle East and Africa Gene Therapy Market Status by Manufacturers
9.3 Middle East and Africa Gene Therapy Market Status by Type (2016-2021)
9.3.1 Middle East and Africa Gene Therapy Sales by Type (2016-2021)
9.3.2 Middle East and Africa Gene Therapy Revenue by Type (2016-2021)
9.4 Middle East and Africa Gene Therapy Market Status by Downstream Industry (2016-2021)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF GENE THERAPY
10.1 Global Economy Situation and Trend Overview
10.2 Gene Therapy Downstream Industry Situation and Trend Overview
CHAPTER 11 GENE THERAPY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Gene Therapy by Major Manufacturers
11.2 Production Value of Gene Therapy by Major Manufacturers
11.3 Basic Information of Gene Therapy by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Gene Therapy Major Manufacturer
11.3.2 Employees and Revenue Level of Gene Therapy Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 GENE THERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Biogen
12.1.1 Company profile
12.1.2 Representative Gene Therapy Product
12.1.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Biogen
12.2 Novartis
12.2.1 Company profile
12.2.2 Representative Gene Therapy Product
12.2.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Novartis
12.3 Gilead Sciences
12.3.1 Company profile
12.3.2 Representative Gene Therapy Product
12.3.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Gilead Sciences
12.4 Sarepta Therapeutics
12.4.1 Company profile
12.4.2 Representative Gene Therapy Product
12.4.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Sarepta Therapeutics
12.5 Alnylam Pharmaceuticals
12.5.1 Company profile
12.5.2 Representative Gene Therapy Product
12.5.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Alnylam Pharmaceuticals
12.6 Amgen
12.6.1 Company profile
12.6.2 Representative Gene Therapy Product
12.6.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Amgen
12.7 Spark Therapeutics
12.7.1 Company profile
12.7.2 Representative Gene Therapy Product
12.7.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Spark Therapeutics
12.8 Akcea Therapeutics
12.8.1 Company profile
12.8.2 Representative Gene Therapy Product
12.8.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Akcea Therapeutics
12.9 bluebird bio
12.9.1 Company profile
12.9.2 Representative Gene Therapy Product
12.9.3 Gene Therapy Sales, Revenue, Price and Gross Margin of bluebird bio
12.10 Sunway Biotech
12.10.1 Company profile
12.10.2 Representative Gene Therapy Product
12.10.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Sunway Biotech
12.11 SIBIONO
12.11.1 Company profile
12.11.2 Representative Gene Therapy Product
12.11.3 Gene Therapy Sales, Revenue, Price and Gross Margin of SIBIONO
12.12 AnGes
12.12.1 Company profile
12.12.2 Representative Gene Therapy Product
12.12.3 Gene Therapy Sales, Revenue, Price and Gross Margin of AnGes
12.13 Orchard Therapeutics
12.13.1 Company profile
12.13.2 Representative Gene Therapy Product
12.13.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Orchard Therapeutics
12.14 Human Stem Cells Institute
12.14.1 Company profile
12.14.2 Representative Gene Therapy Product
12.14.3 Gene Therapy Sales, Revenue, Price and Gross Margin of Human Stem Cells Institute
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GENE THERAPY
13.1 Industry Chain of Gene Therapy
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF GENE THERAPY
14.1 Cost Structure Analysis of Gene Therapy
14.2 Raw Materials Cost Analysis of Gene Therapy
14.3 Labor Cost Analysis of Gene Therapy
14.4 Manufacturing Expenses Analysis of Gene Therapy
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
